EREG and breast carcinoma: Matrix metalloproteinase-1 (MMP-1), matrix metalloproteinase-2 (MMP-2), cyclooxygenase-2 (COX-2), and epiregulin (EREG) synergistically promote breast carcinoma intravasation by stimulating neoangiogenesis and leaky blood vessel formation [7].